Equatorial Guinea
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 1.26 (1.09 - 1.43) | 2019 | Modelled | IHME |
| 1.28 (1.12 - 1.44) | 2018 | Modelled | IHME |
| 1.3 (1.14 - 1.47) | 2017 | Modelled | IHME |
| 1.34 (1.17 - 1.51) | 2016 | Modelled | IHME |
| 1.37 (1.19 - 1.56) | 2015 | Modelled | IHME |
| 1.39 (1.21 - 1.59) | 2014 | Modelled | IHME |
| 1.4 (1.22 - 1.61) | 2013 | Modelled | IHME |
| 1.41 (1.22 - 1.62) | 2012 | Modelled | IHME |
| 1.43 (1.23 - 1.64) | 2011 | Modelled | IHME |
| 1.44 (1.23 - 1.67) | 2010 | Modelled | IHME |
| 1.46 (1.24 - 1.68) | 2009 | Modelled | IHME |
| 1.47 (1.26 - 1.71) | 2008 | Modelled | IHME |
| 1.5 (1.28 - 1.72) | 2007 | Modelled | IHME |
| 1.52 (1.31 - 1.75) | 2006 | Modelled | IHME |
| 1.55 (1.32 - 1.79) | 2005 | Modelled | IHME |
| 1.58 (1.36 - 1.83) | 2004 | Modelled | IHME |
| 1.63 (1.40 - 1.88) | 2003 | Modelled | IHME |
| 1.68 (1.45 - 1.95) | 2002 | Modelled | IHME |
| 1.73 (1.49 - 2.02) | 2001 | Modelled | IHME |
| 1.79 (1.52 - 2.10) | 2000 | Modelled | IHME |
| 1.84 (1.57 - 2.16) | 1999 | Modelled | IHME |
| 1.9 (1.62 - 2.22) | 1998 | Modelled | IHME |
| 1.96 (1.67 - 2.30) | 1997 | Modelled | IHME |
| 2.01 (1.70 - 2.35) | 1996 | Modelled | IHME |
| 2.06 (1.74 - 2.40) | 1995 | Modelled | IHME |
| 2.09 (1.77 - 2.44) | 1994 | Modelled | IHME |
| 2.13 (1.80 - 2.47) | 1993 | Modelled | IHME |
| 2.16 (1.83 - 2.50) | 1992 | Modelled | IHME |
| 2.18 (1.85 - 2.53) | 1991 | Modelled | IHME |
| 2.2 (1.86 - 2.56) | 1990 | Modelled | IHME |
| 9.34 (7.48 - 11.40) | 2015 | Modelled | WHO |
| 8.81 (7.66 - 10.12) | 2013 | Modelled | Schweitzer et al, 2015 |
Showing out of
Show more
Children under-5 years
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0.48 (0.36 - 0.62) | 2019 | Modelled | IHME |
| 0.49 (0.37 - 0.63) | 2018 | Modelled | IHME |
| 0.5 (0.38 - 0.64) | 2017 | Modelled | IHME |
| 0.66 (0.51 - 0.83) | 2016 | Modelled | IHME |
| 0.83 (0.63 - 1.06) | 2015 | Modelled | IHME |
| 0.87 (0.66 - 1.11) | 2014 | Modelled | IHME |
| 0.9 (0.68 - 1.14) | 2013 | Modelled | IHME |
| 0.91 (0.69 - 1.17) | 2012 | Modelled | IHME |
| 0.93 (0.70 - 1.19) | 2011 | Modelled | IHME |
| 0.95 (0.71 - 1.23) | 2010 | Modelled | IHME |
| 0.97 (0.73 - 1.26) | 2009 | Modelled | IHME |
| 0.99 (0.75 - 1.28) | 2008 | Modelled | IHME |
| 1.02 (0.77 - 1.31) | 2007 | Modelled | IHME |
| 1.04 (0.78 - 1.34) | 2006 | Modelled | IHME |
| 1.07 (0.81 - 1.38) | 2005 | Modelled | IHME |
| 1.11 (0.85 - 1.42) | 2004 | Modelled | IHME |
| 1.16 (0.89 - 1.48) | 2003 | Modelled | IHME |
| 1.21 (0.93 - 1.55) | 2002 | Modelled | IHME |
| 1.27 (0.98 - 1.62) | 2001 | Modelled | IHME |
| 1.33 (1.01 - 1.70) | 2000 | Modelled | IHME |
| 1.38 (1.06 - 1.76) | 1999 | Modelled | IHME |
| 1.43 (1.10 - 1.84) | 1998 | Modelled | IHME |
| 1.49 (1.14 - 1.91) | 1997 | Modelled | IHME |
| 1.54 (1.17 - 1.97) | 1996 | Modelled | IHME |
| 1.58 (1.20 - 2.03) | 1995 | Modelled | IHME |
| 1.62 (1.23 - 2.05) | 1994 | Modelled | IHME |
| 1.65 (1.26 - 2.08) | 1993 | Modelled | IHME |
| 1.68 (1.29 - 2.11) | 1992 | Modelled | IHME |
| 1.71 (1.31 - 2.13) | 1991 | Modelled | IHME |
| 1.73 (1.32 - 2.16) | 1990 | Modelled | IHME |
| 8.66 (6.75 - 11.20) | 2015 | Modelled | WHO |
Showing out of
Show more
Number of people living with chronic HBV
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 9,466 (8,024 - 11,033) | 1990 | Modelled | IHME |
| 9,778 (8,296 - 11,326) | 1991 | Modelled | IHME |
| 10,081 (8,553 - 11,684) | 1992 | Modelled | IHME |
| 10,375 (8,795 - 12,049) | 1993 | Modelled | IHME |
| 10,663 (9,017 - 12,410) | 1994 | Modelled | IHME |
| 10,946 (9,244 - 12,785) | 1995 | Modelled | IHME |
| 11,197 (9,475 - 13,090) | 1996 | Modelled | IHME |
| 11,399 (9,703 - 13,386) | 1997 | Modelled | IHME |
| 11,575 (9,863 - 13,535) | 1998 | Modelled | IHME |
| 11,746 (10,038 - 13,759) | 1999 | Modelled | IHME |
| 11,940 (10,169 - 14,009) | 2000 | Modelled | IHME |
| 12,142 (10,403 - 14,150) | 2001 | Modelled | IHME |
| 12,326 (10,609 - 14,308) | 2002 | Modelled | IHME |
| 12,514 (10,755 - 14,455) | 2003 | Modelled | IHME |
| 12,734 (10,931 - 14,705) | 2004 | Modelled | IHME |
| 13,021 (11,131 - 15,031) | 2005 | Modelled | IHME |
| 13,372 (11,494 - 15,377) | 2006 | Modelled | IHME |
| 13,752 (11,804 - 15,843) | 2007 | Modelled | IHME |
| 14,156 (12,096 - 16,368) | 2008 | Modelled | IHME |
| 14,579 (12,453 - 16,839) | 2009 | Modelled | IHME |
| 15,012 (12,857 - 17,370) | 2010 | Modelled | IHME |
| 15,465 (13,300 - 17,803) | 2011 | Modelled | IHME |
| 15,939 (13,771 - 18,284) | 2012 | Modelled | IHME |
| 16,412 (14,229 - 18,778) | 2013 | Modelled | IHME |
| 16,853 (14,618 - 19,214) | 2014 | Modelled | IHME |
| 17,223 (14,951 - 19,601) | 2015 | Modelled | IHME |
| 17,355 (15,209 - 19,577) | 2016 | Modelled | IHME |
| 17,410 (15,271 - 19,706) | 2017 | Modelled | IHME |
| 17,603 (15,475 - 19,797) | 2018 | Modelled | IHME |
| 17,861 (15,511 - 20,256) | 2019 | Modelled | IHME |
Showing out of
Show more
HBV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 3.29 (1.97 - 5.22) | 2019 | Modelled | IHME |
| 3.27 (1.98 - 5.07) | 2018 | Modelled | IHME |
| 3.22 (1.93 - 5.10) | 2017 | Modelled | IHME |
| 3.18 (1.93 - 5.01) | 2016 | Modelled | IHME |
| 3.12 (1.87 - 4.94) | 2015 | Modelled | IHME |
| 3.15 (1.91 - 4.93) | 2014 | Modelled | IHME |
| 3.21 (1.96 - 5.03) | 2013 | Modelled | IHME |
| 3.3 (2.02 - 5.17) | 2012 | Modelled | IHME |
| 3.36 (2.05 - 5.17) | 2011 | Modelled | IHME |
| 3.33 (2.03 - 5.09) | 2010 | Modelled | IHME |
| 3.4 (2.06 - 5.18) | 2009 | Modelled | IHME |
| 3.46 (2.09 - 5.27) | 2008 | Modelled | IHME |
| 3.6 (2.17 - 5.46) | 2007 | Modelled | IHME |
| 3.74 (2.25 - 5.63) | 2006 | Modelled | IHME |
| 3.84 (2.31 - 5.66) | 2005 | Modelled | IHME |
| 3.97 (2.43 - 5.81) | 2004 | Modelled | IHME |
| 4.13 (2.55 - 6.03) | 2003 | Modelled | IHME |
| 4.34 (2.69 - 6.28) | 2002 | Modelled | IHME |
| 4.74 (2.98 - 6.79) | 2001 | Modelled | IHME |
| 5.14 (3.25 - 7.36) | 2000 | Modelled | IHME |
| 5.48 (3.50 - 7.83) | 1999 | Modelled | IHME |
| 5.81 (3.72 - 8.34) | 1998 | Modelled | IHME |
| 6.23 (4.01 - 9.03) | 1997 | Modelled | IHME |
| 6.81 (4.36 - 10) | 1996 | Modelled | IHME |
| 7.11 (4.51 - 10.60) | 1995 | Modelled | IHME |
| 7.37 (4.66 - 11) | 1994 | Modelled | IHME |
| 7.75 (4.92 - 11.70) | 1993 | Modelled | IHME |
| 8.1 (5.08 - 12.20) | 1992 | Modelled | IHME |
| 8.5 (5.29 - 12.90) | 1991 | Modelled | IHME |
| 8.81 (5.56 - 13.60) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 47 (28 - 74) | 2019 | Modelled | IHME |
| 45 (27 - 70) | 2018 | Modelled | IHME |
| 43 (26 - 68) | 2017 | Modelled | IHME |
| 41 (25 - 65) | 2016 | Modelled | IHME |
| 39 (24 - 62) | 2015 | Modelled | IHME |
| 38 (23 - 60) | 2014 | Modelled | IHME |
| 38 (23 - 59) | 2013 | Modelled | IHME |
| 37 (23 - 58) | 2012 | Modelled | IHME |
| 36 (22 - 56) | 2011 | Modelled | IHME |
| 35 (21 - 53) | 2010 | Modelled | IHME |
| 34 (21 - 52) | 2009 | Modelled | IHME |
| 33 (20 - 51) | 2008 | Modelled | IHME |
| 33 (20 - 50) | 2007 | Modelled | IHME |
| 33 (20 - 50) | 2006 | Modelled | IHME |
| 32 (19 - 48) | 2005 | Modelled | IHME |
| 32 (20 - 47) | 2004 | Modelled | IHME |
| 32 (20 - 46) | 2003 | Modelled | IHME |
| 32 (20 - 46) | 2002 | Modelled | IHME |
| 33 (21 - 48) | 2001 | Modelled | IHME |
| 34 (22 - 49) | 2000 | Modelled | IHME |
| 35 (22 - 50) | 1999 | Modelled | IHME |
| 35 (23 - 51) | 1998 | Modelled | IHME |
| 36 (23 - 53) | 1997 | Modelled | IHME |
| 38 (24 - 56) | 1996 | Modelled | IHME |
| 38 (24 - 56) | 1995 | Modelled | IHME |
| 38 (24 - 56) | 1994 | Modelled | IHME |
| 38 (24 - 57) | 1993 | Modelled | IHME |
| 38 (24 - 57) | 1992 | Modelled | IHME |
| 38 (24 - 58) | 1991 | Modelled | IHME |
| 38 (24 - 58) | 1990 | Modelled | IHME |
| 165 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 27 (21 - 35) | 2019 | Modelled | IHME |
| 27 (21 - 34) | 2018 | Modelled | IHME |
| 27 (21 - 34) | 2017 | Modelled | IHME |
| 27 (20 - 34) | 2016 | Modelled | IHME |
| 27 (20 - 34) | 2015 | Modelled | IHME |
| 27 (20 - 34) | 2014 | Modelled | IHME |
| 27 (20 - 34) | 2013 | Modelled | IHME |
| 27 (20 - 34) | 2012 | Modelled | IHME |
| 27 (20 - 34) | 2011 | Modelled | IHME |
| 27 (20 - 34) | 2010 | Modelled | IHME |
| 26 (20 - 34) | 2009 | Modelled | IHME |
| 26 (20 - 34) | 2008 | Modelled | IHME |
| 26 (20 - 34) | 2007 | Modelled | IHME |
| 26 (20 - 34) | 2006 | Modelled | IHME |
| 26 (20 - 34) | 2005 | Modelled | IHME |
| 26 (20 - 34) | 2004 | Modelled | IHME |
| 26 (20 - 34) | 2003 | Modelled | IHME |
| 26 (20 - 34) | 2002 | Modelled | IHME |
| 26 (20 - 34) | 2001 | Modelled | IHME |
| 26 (20 - 34) | 2000 | Modelled | IHME |
| 26 (20 - 34) | 1999 | Modelled | IHME |
| 26 (20 - 35) | 1998 | Modelled | IHME |
| 27 (20 - 35) | 1997 | Modelled | IHME |
| 27 (20 - 35) | 1996 | Modelled | IHME |
| 27 (20 - 35) | 1995 | Modelled | IHME |
| 27 (20 - 35) | 1994 | Modelled | IHME |
| 27 (20 - 35) | 1993 | Modelled | IHME |
| 27 (20 - 35) | 1992 | Modelled | IHME |
| 27 (20 - 35) | 1991 | Modelled | IHME |
| 26 (20 - 35) | 1990 | Modelled | IHME |
Showing out of
Show more
Coverage of 3-dose hepatitis B vaccine
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2018
Eligible for HBV generic medicines
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 2.27 (1.82 - 2.87) | 2019 | Modelled | IHME |
| 2.27 (1.82 - 2.85) | 2018 | Modelled | IHME |
| 2.27 (1.80 - 2.86) | 2017 | Modelled | IHME |
| 2.26 (1.82 - 2.85) | 2016 | Modelled | IHME |
| 2.26 (1.81 - 2.83) | 2015 | Modelled | IHME |
| 2.27 (1.82 - 2.84) | 2014 | Modelled | IHME |
| 2.3 (1.86 - 2.88) | 2013 | Modelled | IHME |
| 2.34 (1.89 - 2.93) | 2012 | Modelled | IHME |
| 2.38 (1.93 - 2.99) | 2011 | Modelled | IHME |
| 2.43 (1.95 - 3.05) | 2010 | Modelled | IHME |
| 2.47 (2 - 3.11) | 2009 | Modelled | IHME |
| 2.53 (2.04 - 3.18) | 2008 | Modelled | IHME |
| 2.59 (2.08 - 3.24) | 2007 | Modelled | IHME |
| 2.66 (2.14 - 3.34) | 2006 | Modelled | IHME |
| 2.73 (2.19 - 3.42) | 2005 | Modelled | IHME |
| 2.81 (2.26 - 3.51) | 2004 | Modelled | IHME |
| 2.9 (2.33 - 3.63) | 2003 | Modelled | IHME |
| 3 (2.42 - 3.77) | 2002 | Modelled | IHME |
| 3.1 (2.50 - 3.89) | 2001 | Modelled | IHME |
| 3.21 (2.58 - 4.03) | 2000 | Modelled | IHME |
| 3.31 (2.66 - 4.15) | 1999 | Modelled | IHME |
| 3.42 (2.75 - 4.29) | 1998 | Modelled | IHME |
| 3.54 (2.84 - 4.47) | 1997 | Modelled | IHME |
| 3.65 (2.92 - 4.57) | 1996 | Modelled | IHME |
| 3.75 (2.99 - 4.70) | 1995 | Modelled | IHME |
| 3.84 (3.08 - 4.82) | 1994 | Modelled | IHME |
| 3.92 (3.15 - 4.93) | 1993 | Modelled | IHME |
| 4.01 (3.21 - 5.07) | 1992 | Modelled | IHME |
| 4.09 (3.29 - 5.15) | 1991 | Modelled | IHME |
| 4.16 (3.34 - 5.24) | 1990 | Modelled | IHME |
Showing out of
Show more
Women of childbearing age (15–49 years)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0.44 (0 - 0.45) | 2019 | Modelled | Dugan et al., 2021 |
Number of people living with chronic HCV (RNA+/cAg)
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 17,900 (14,392 - 22,571) | 1990 | Modelled | IHME |
| 18,321 (14,748 - 23,078) | 1991 | Modelled | IHME |
| 18,736 (15,004 - 23,702) | 1992 | Modelled | IHME |
| 19,143 (15,349 - 24,062) | 1993 | Modelled | IHME |
| 19,538 (15,708 - 24,551) | 1994 | Modelled | IHME |
| 19,920 (15,909 - 25,016) | 1995 | Modelled | IHME |
| 20,263 (16,210 - 25,419) | 1996 | Modelled | IHME |
| 20,562 (16,490 - 25,993) | 1997 | Modelled | IHME |
| 20,840 (16,730 - 26,124) | 1998 | Modelled | IHME |
| 21,116 (16,970 - 26,442) | 1999 | Modelled | IHME |
| 21,419 (17,232 - 26,914) | 2000 | Modelled | IHME |
| 21,733 (17,504 - 27,233) | 2001 | Modelled | IHME |
| 22,028 (17,739 - 27,623) | 2002 | Modelled | IHME |
| 22,322 (17,931 - 27,878) | 2003 | Modelled | IHME |
| 22,638 (18,186 - 28,278) | 2004 | Modelled | IHME |
| 23,006 (18,425 - 28,833) | 2005 | Modelled | IHME |
| 23,415 (18,831 - 29,381) | 2006 | Modelled | IHME |
| 23,839 (19,150 - 29,796) | 2007 | Modelled | IHME |
| 24,286 (19,567 - 30,498) | 2008 | Modelled | IHME |
| 24,773 (20,004 - 31,147) | 2009 | Modelled | IHME |
| 25,314 (20,345 - 31,835) | 2010 | Modelled | IHME |
| 25,851 (20,918 - 32,407) | 2011 | Modelled | IHME |
| 26,356 (21,264 - 32,969) | 2012 | Modelled | IHME |
| 26,897 (21,689 - 33,699) | 2013 | Modelled | IHME |
| 27,544 (22,102 - 34,440) | 2014 | Modelled | IHME |
| 28,368 (22,684 - 35,525) | 2015 | Modelled | IHME |
| 29,335 (23,530 - 36,901) | 2016 | Modelled | IHME |
| 30,312 (24,131 - 38,208) | 2017 | Modelled | IHME |
| 31,285 (25,092 - 39,302) | 2018 | Modelled | IHME |
| 32,283 (25,884 - 40,694) | 2019 | Modelled | IHME |
Showing out of
Show more
Women of childbearing age (15–49 years)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 1,300 (0 - 1,300) | 2019 | Modelled | Dugan et al., 2021 |
HCV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 2.94 (1.81 - 4.60) | 2019 | Modelled | IHME |
| 2.94 (1.84 - 4.68) | 2018 | Modelled | IHME |
| 2.9 (1.83 - 4.53) | 2017 | Modelled | IHME |
| 2.85 (1.79 - 4.50) | 2016 | Modelled | IHME |
| 2.8 (1.77 - 4.40) | 2015 | Modelled | IHME |
| 2.81 (1.77 - 4.39) | 2014 | Modelled | IHME |
| 2.85 (1.81 - 4.43) | 2013 | Modelled | IHME |
| 2.91 (1.82 - 4.51) | 2012 | Modelled | IHME |
| 2.94 (1.83 - 4.61) | 2011 | Modelled | IHME |
| 2.9 (1.79 - 4.53) | 2010 | Modelled | IHME |
| 2.96 (1.82 - 4.55) | 2009 | Modelled | IHME |
| 3.01 (1.85 - 4.56) | 2008 | Modelled | IHME |
| 3.13 (1.96 - 4.72) | 2007 | Modelled | IHME |
| 3.25 (2.03 - 4.89) | 2006 | Modelled | IHME |
| 3.33 (2.13 - 5.01) | 2005 | Modelled | IHME |
| 3.44 (2.22 - 5.09) | 2004 | Modelled | IHME |
| 3.55 (2.30 - 5.21) | 2003 | Modelled | IHME |
| 3.72 (2.42 - 5.44) | 2002 | Modelled | IHME |
| 4.03 (2.62 - 5.83) | 2001 | Modelled | IHME |
| 4.33 (2.85 - 6.20) | 2000 | Modelled | IHME |
| 4.58 (3.03 - 6.57) | 1999 | Modelled | IHME |
| 4.79 (3.20 - 6.81) | 1998 | Modelled | IHME |
| 5.07 (3.35 - 7.34) | 1997 | Modelled | IHME |
| 5.48 (3.59 - 8.12) | 1996 | Modelled | IHME |
| 5.67 (3.65 - 8.38) | 1995 | Modelled | IHME |
| 5.85 (3.75 - 8.60) | 1994 | Modelled | IHME |
| 6.12 (3.92 - 9.05) | 1993 | Modelled | IHME |
| 6.37 (4.04 - 9.42) | 1992 | Modelled | IHME |
| 6.68 (4.26 - 9.80) | 1991 | Modelled | IHME |
| 6.93 (4.37 - 10.30) | 1990 | Modelled | IHME |
Showing out of
Show more
HCV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 42 (26 - 65) | 2019 | Modelled | IHME |
| 40 (25 - 65) | 2018 | Modelled | IHME |
| 39 (24 - 61) | 2017 | Modelled | IHME |
| 37 (23 - 58) | 2016 | Modelled | IHME |
| 35 (22 - 55) | 2015 | Modelled | IHME |
| 34 (21 - 53) | 2014 | Modelled | IHME |
| 33 (21 - 52) | 2013 | Modelled | IHME |
| 33 (20 - 51) | 2012 | Modelled | IHME |
| 32 (20 - 50) | 2011 | Modelled | IHME |
| 30 (19 - 47) | 2010 | Modelled | IHME |
| 30 (18 - 46) | 2009 | Modelled | IHME |
| 29 (18 - 44) | 2008 | Modelled | IHME |
| 29 (18 - 43) | 2007 | Modelled | IHME |
| 29 (18 - 43) | 2006 | Modelled | IHME |
| 28 (18 - 42) | 2005 | Modelled | IHME |
| 28 (18 - 41) | 2004 | Modelled | IHME |
| 27 (18 - 40) | 2003 | Modelled | IHME |
| 27 (18 - 40) | 2002 | Modelled | IHME |
| 28 (18 - 41) | 2001 | Modelled | IHME |
| 29 (19 - 41) | 2000 | Modelled | IHME |
| 29 (19 - 42) | 1999 | Modelled | IHME |
| 29 (19 - 41) | 1998 | Modelled | IHME |
| 29 (19 - 43) | 1997 | Modelled | IHME |
| 30 (20 - 45) | 1996 | Modelled | IHME |
| 30 (19 - 45) | 1995 | Modelled | IHME |
| 30 (19 - 44) | 1994 | Modelled | IHME |
| 30 (19 - 44) | 1993 | Modelled | IHME |
| 30 (19 - 44) | 1992 | Modelled | IHME |
| 30 (19 - 44) | 1991 | Modelled | IHME |
| 30 (19 - 44) | 1990 | Modelled | IHME |
| 97 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 39 (30 - 48) | 2019 | Modelled | IHME |
| 39 (30 - 48) | 2018 | Modelled | IHME |
| 39 (30 - 48) | 2017 | Modelled | IHME |
| 38 (30 - 48) | 2016 | Modelled | IHME |
| 39 (30 - 48) | 2015 | Modelled | IHME |
| 39 (30 - 47) | 2014 | Modelled | IHME |
| 39 (30 - 47) | 2013 | Modelled | IHME |
| 38 (30 - 47) | 2012 | Modelled | IHME |
| 38 (29 - 47) | 2011 | Modelled | IHME |
| 38 (29 - 47) | 2010 | Modelled | IHME |
| 38 (29 - 47) | 2009 | Modelled | IHME |
| 38 (29 - 47) | 2008 | Modelled | IHME |
| 38 (29 - 47) | 2007 | Modelled | IHME |
| 38 (29 - 47) | 2006 | Modelled | IHME |
| 38 (29 - 47) | 2005 | Modelled | IHME |
| 39 (30 - 47) | 2004 | Modelled | IHME |
| 39 (30 - 48) | 2003 | Modelled | IHME |
| 39 (30 - 48) | 2002 | Modelled | IHME |
| 39 (31 - 48) | 2001 | Modelled | IHME |
| 39 (31 - 48) | 2000 | Modelled | IHME |
| 40 (31 - 48) | 1999 | Modelled | IHME |
| 40 (31 - 48) | 1998 | Modelled | IHME |
| 40 (31 - 49) | 1997 | Modelled | IHME |
| 41 (31 - 49) | 1996 | Modelled | IHME |
| 41 (32 - 49) | 1995 | Modelled | IHME |
| 41 (32 - 50) | 1994 | Modelled | IHME |
| 41 (32 - 50) | 1993 | Modelled | IHME |
| 41 (32 - 50) | 1992 | Modelled | IHME |
| 41 (33 - 50) | 1991 | Modelled | IHME |
| 42 (33 - 50) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2018
Eligible for HBV generic medicines
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
Survey/surveillance
No data available
No data available
Hepatitis related deaths (national)
Prevalence < 5
HBV
0.48
(%)
2019, latest modelled
(0.36 - 0.62(%))
IHME
Prevalence PWID
No data available
Birth dose vaccination coverage (national)
Survey/surveillance
No data available
No. of syringes/PWID/year
Survey/surveillance
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines